ADVFN US – Market Content Editor
-

Alaska Airlines unveils business class suites for new Europe and Asia routes
Alaska Airlines (NYSE:ALK) has introduced a new International Business Class offering aboard its Boeing 787-9 Dreamliners as the carrier expands service to destinations in Europe and Asia this spring. The upgraded cabin features fully lie-flat suites equipped with privacy doors, direct aisle access, and 18-inch HD entertainment screens. Travelers will also be served multi-course meals…
-

Agios shares jump as FDA discussions advance mitapivat approval pathway
Agios Pharmaceuticals (NASDAQ:AGIO) shares climbed about 12% on Tuesday after the company reported progress toward a potential accelerated U.S. approval for its drug candidate mitapivat in treating sickle cell disease following a pre-supplemental New Drug Application meeting with the U.S. Food and Drug Administration. During the discussions, the FDA advised Agios to submit a proposal…
-

Cintas secures $2 billion revolving credit facility extending to 2031
Cintas Corporation (NASDAQ:CTAS) announced that its wholly owned subsidiary, Cintas Corporation No. 2, entered into a new $2 billion revolving credit facility on March 27, 2026. The agreement includes a letter of credit sub-facility of up to $300 million and a swing line sub-facility of up to $150 million. KeyBank National Association is serving as…
-

Scholar Rock shares jump after FDA resubmission for SMA therapy
Scholar Rock (NASDAQ:SRRK) shares climbed about 12% on Tuesday after the company announced it had resubmitted its Biologics License Application (BLA) to the U.S. Food and Drug Administration for apitegromab, a therapy aimed at treating children and adults with spinal muscular atrophy (SMA). The updated filing includes Catalent Indiana LLC, a facility owned by Novo…
-

Alkermes shares jump 13% after Lilly announces sleep-disorder acquisition
Shares of Alkermes (NASDAQ:ALKS) climbed about 13% on Tuesday after Eli Lilly (NYSE:LLY) revealed plans to acquire Centessa Pharmaceuticals (NASDAQ:CNTA), a biotechnology company developing therapies for sleep-related disorders. Under the agreement, Lilly will purchase all outstanding and to-be-issued Centessa shares for $38.00 in cash per share, along with a non-transferable contingent value right (CVR) that…
-

Xtant Medical shares drop nearly 5% as weak 2026 outlook overshadows Q4 beat
Xtant Medical Holdings (AMEX:XTNT) shares fell about 4.7% in pre-market trading Tuesday after the company reported fourth-quarter results that topped expectations but issued 2026 revenue guidance well below Wall Street forecasts. For the quarter, the medical technology firm posted adjusted earnings per share of $0.00, outperforming the analyst estimate of -$0.01. Revenue came in at…
-

Weight Watchers introduces discounted Wegovy pricing through Novo Nordisk partnership
WW International Inc. (NASDAQ:WW) said its Med+ members will gain access to reduced pricing for Wegovy through an expanded collaboration with Novo Nordisk (NYSE:NVO), lowering out-of-pocket costs for patients paying without insurance. The program gives Weight Watchers Med+ members access to subscription-based pricing for Wegovy doses, potentially delivering savings of up to $1,200 per year…
-

Nebius shares rise after unveiling plans for major AI facility in Finland
Nebius Group (NASDAQ:NBIS) shares climbed about 3.5% on Tuesday after the company revealed plans to construct a 310 MW AI factory in Lappeenranta, Finland, with initial capacity expected to come online in 2027. Once fully built, the facility is expected to rank among Europe’s largest dedicated AI infrastructure hubs and forms part of Nebius’s broader…
-

Aehr Test shares jump 13% after securing silicon photonics system order
Shares of Aehr Test Systems (NASDAQ:AEHR) climbed 13% after the company revealed it had received an initial order from a new customer described as a global leader in networking equipment and a key supplier to the data center optical transceiver market. The order covers several systems intended for both engineering qualification and high-volume production. These…
-

Novo Nordisk introduces discounted Wegovy subscription plan in the U.S.
Novo Nordisk (NYSE:NVO) has rolled out a new subscription-based pricing program in the United States aimed at patients paying out of pocket for Wegovy without insurance coverage. The initiative provides monthly discounts of up to 29% through several telehealth providers. Beginning Tuesday, eligible self-pay patients can obtain three-, six-, or 12-month supplies of Wegovy at…